Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: March 2009
Vimpat Approved in Europe
02 March 2009 | New Clinical Evidence
• Improved seizure control when added to other antiepileptic drugs (AEDs) (1) • High long-term retention rate • A dual mode of action... Read more
Azarga
02 March 2009 | New Products
Company: Alcon Laboratories (UK) Ltd. Legal category: Prescription. GMS. Prohibited in specific sports. Active ingredients: Brinzolamide 10mg and timolol (as maleate) 5mg. Description: Eye drops. White to off white uniform suspension, pH 7.2. Presentation: 5ml, €17.80. Indications: Decrease of intraocular... Read more
CanOral
02 March 2009 | New Products
Company: Bayer Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Fluconazole 150mg. Description: Opaque light blue hard capsule (size 1) printed CAN 150. Presentation: 1, €5.49. Indication: Acute or recurrent genital candidiasis, i.e. candidal vaginitis and candidal balanitis. The... Read more
Casomide
02 March 2009 | New Products
Company: Clonmel Healthcare Ltd. Legal category: Prescription. HT. Sport permitted. Active ingredient: Bicalutamide 50mg. Description: White round biconvex film-coated tablet. Presentation: 28, price available on request. Indications: Advanced prostate cancer: In combination with LHRH analogue therapy or surgical castration. Locally... Read more
Ciprofloxacin Teva
02 March 2009 | New Products
Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Ciprofloxacin 250mg, 500mg. Description: White, film-ctd tablets with breakline. The tablet can be divided into equal halves. 250mg: Biconvex, round marked CIP 250. 500mg: Capsule shaped marked CIP500... Read more
Efaxil XL
02 March 2009 | New Products
Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine (as hydrochloride) 75mg, 150mg. Description: Respectively, flesh opaque/flesh opaque or scarlet opaque/scarlet opaque, size 0 or size 00 hard gelatine capsules containing two or three white round, biconvex... Read more
Famciclovir Teva
02 March 2009 | New Products
Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Famciclovir 125mg, 250mg. Description: White to off-white, round, film-coated tablets marked 93 on one side. 125mg marked 8117 and 250mg marked 8118 on reverse. Presentation: 125mg-10, €19.01; 250mg-15,... Read more
Osteole
02 March 2009 | New Products
Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Glucosamine sulfate 1500mg. Description: White to slightly yellow crystalline odourless powder for oral solution. Presentation: 30, €20.28. Indication: Treatment of the symptoms of osteoarthritis, i.e. pain and function limitation.... Read more
Relpax
02 March 2009 | New Products
Company: Pfizer Healthcare Ireland. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Eletriptan 40mg (as hydrobromide). Description: Round, convex orange film-coated tablets debossed with REP 40 on one side and Pfizer on the other. Presentation: 6, €27.34. Indication: Acute treatment... Read more
Concerta XL 27mg
02 March 2009 | New Presentations
Company: Janssen-Cilag Ltd. Legal category: Prescription. GMS. Sport prohibited. Controlled Drug. Active ingredient: Methylphenidate hydrochloride 27mg. Description: Capsule-shaped grey prolonged-release tablet with alza 27 printed on one side in black ink. Presentation: 30, €45.06. Indications: As part of a comprehensive... Read more
Infatrini 500ml
02 March 2009 | New Presentations
Nutricia has launched Infatrini in a new 500ml pack for tube feeding. Infatrini is a high energy, nutritionally complete formula for the dietary management of infants with faltering growth or who have increased nutritional requirements and/or require fluid restriction. Infatrini... Read more
Sprycel 100mg
02 March 2009 | New Presentations
Company: Bristol-Myers Squibb Pharmaceuticals. Legal category: Prescription. Sport permitted. Active ingredient: Dasatinib (as monohydrate) 100mg. Description: White to off-white, biconvex, oval film-coated tablet with BMS 100 debossed on one side and 852 on the other side. Presentation: 30. Indications: Treatment... Read more
Discontinuation of AstraZeneca products
02 March 2009 | Discontinued Products
As part of a Global rationalisation process, AstraZeneca Pharmaceuticals (Ireland) Ltd is planning to withdraw the following products from the Irish market: • Avloclor 250mg tablets • Paludrine 100mg tablets • Heminevrin Syrup and capsules • Xyloproct Ointment... Read more
Dexa-Rhinaspray Duo Discontinued
02 March 2009 | Discontinued Products
Boehringer Ingelheim Ireland Ltd would like to advise that due to prolonged lack of availability they have decided to discontinue supply of Dexa-Rhinaspray Duo (tramazoline hydrochloride and dexamethasone isonicotinate).... Read more
Efexor 37.5mg discontinued
02 March 2009 | Discontinued Products
Wyeth Pharmaceuticals Ltd. would like to inform you of their intention to discontinue the marketing of Efexor 37.5mg Tablets. Efexor 37.5mg Tablets will be discontinued when current stock is exhausted.... Read more
